RFK Jr. SLAMS FDA – Abortion Pill DANGER Exposed!

The FDA’s abortion pill has been silently putting women at TWENTY-TWO TIMES more risk than they’ve been telling us, and RFK Jr. just dropped the hammer on this dangerous deception.

At a Glance

• HHS Secretary Robert F. Kennedy Jr. has ordered a complete FDA review of the abortion pill mifepristone after alarming safety data emerged
• Nearly 11% of women experienced serious adverse events after taking mifepristone – 22 times higher than the 0.5% risk stated on FDA labels
• Over 5% of women required second abortion procedures due to the pill failing to complete the abortion
• Study analyzed insurance claims data from 865,727 mifepristone prescriptions between 2017-2023
• Serious complications included sepsis, infection, and hemorrhaging within 45 days of taking the pill

FDA Caught Downplaying Abortion Pill Dangers

In a move that’s sending shockwaves through the pro-abortion industrial complex, Health and Human Services Secretary Robert F. Kennedy Jr. has ordered a complete review of the abortion pill mifepristone after damning evidence revealed its dangers have been drastically underreported. For years, the FDA has claimed the pill causes serious adverse effects in less than 0.5% of women. But according to new data, that number is actually closer to 11% – a staggering 22 times higher than what women have been told. This revelation exposes yet another case of government agencies putting political agendas ahead of women’s health and safety.

“It’s alarming,” Kennedy told lawmakers during a Senate committee hearing, clearly troubled by the findings that suggest thousands of women have been misled about the risks they’re taking. “I have asked Marty Makary, who is the director at FDA, to do a complete review and report back.”

The Disturbing Numbers Big Abortion Doesn’t Want You to See

The study that prompted Kennedy’s action came from the Ethics & Public Policy Center, which analyzed insurance claims data from a staggering 865,727 mifepristone prescriptions over a six-year period. The findings are nothing short of shocking: 10.93% of women experienced serious adverse events including sepsis, infection, or hemorrhaging within just 45 days of taking the pill. Remember, this isn’t coming from some fringe anti-abortion group – this is actual insurance claims data that can’t be dismissed away with the usual pro-abortion talking points.

“Clearly, it indicates that at the very least the label should be changed,” RFK Jr. stated, highlighting the bare minimum that should be done in response to these findings.

Failed Abortions Putting Women at Further Risk

As if the risk of serious medical complications wasn’t enough, the study also revealed that more than 5% of women required a second abortion procedure after the pill failed to complete the job. This isn’t just inconvenient – it’s potentially deadly. Incomplete abortions can lead to infection, hemorrhage, and even sepsis if not properly treated. Yet the FDA, under previous administrations, has been consistently loosening restrictions on these drugs rather than tightening them in response to safety concerns.

“We applaud Robert F. Kennedy Jr. for his swift directive to FDA for a thorough study of the dangerous chemical abortion pill,” said Doug Truax from the Foundation for the Restoration of America.

Obama-Era Expansion Despite Known Risks

What makes this situation even more infuriating is that mifepristone was originally approved by the FDA in 2000 for use up to seven weeks into pregnancy. But under President Obama, that timeline was extended to 10 weeks – despite growing evidence of increased risks with later usage. The FDA then proceeded to remove the requirement for in-person acquisition of these pills during the Biden administration, allowing them to be purchased online without direct medical supervision. It’s almost as if keeping abortion accessible was more important than keeping women safe.

The contrast between the abortion industry’s “safe, legal, and rare” mantra and the reality of what’s happening couldn’t be more stark. When 1 in 10 women are experiencing serious medical complications from a drug that’s supposed to be “safe,” we’re not talking about rare events anymore – we’re talking about a public health crisis that’s been deliberately hidden from view. How many women have made life-altering decisions based on risk assessments that were off by a factor of 22? The answer to that question should trouble anyone with a conscience, regardless of their position on abortion itself.